Francomano Robert has filed 5 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 20000 shares of SELLAS Life Sciences Group, Inc. ($SLS) on January 22, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2024 | SELLAS Life Sciences Group, Inc. | $SLS | Francomano Robert | Chief Commercial Officer | A | Common Stock | 20000 | $0.00 | 40,918.0000 | 0 | 95.61% | 0.00% |
| Jan. 22, 2024 | SELLAS Life Sciences Group, Inc. | $SLS | Francomano Robert | Chief Commercial Officer | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 6, 2023 | SELLAS Life Sciences Group, Inc. | $SLS | Francomano Robert | Chief Commercial Officer | J | Class A Common Stock | 1082 | $1.08 | 20,918.0000 | 0 | 4.92% | 0.00% |
| Feb. 2, 2023 | SELLAS Life Sciences Group, Inc. | $SLS | Francomano Robert | Chief Commercial Officer | A | Common Stock | 12000 | $0.00 | 12,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 2, 2023 | SELLAS Life Sciences Group, Inc. | $SLS | Francomano Robert | Chief Commercial Officer | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |